Importantly, our results show that PPAR-γ is partially responsible for promoting tumorigenesis in Dnmt3a-deficient epidermis, which considering that human skin tumors express lower levels of Dnmt3a, might provide us with a new therapeutic antitumor avenue against squamous cell carcinomas. This evidence concerns the gene PPARG and squamous cell carcinoma.